Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.15 USD
+0.01 (0.09%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $11.14 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth NA Momentum NA VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2025
Time: AMC |
6/2025 | $0.12 | 0.00% |
Earnings Summary
For their last quarter, Dynavax Technologies (DVAX) reported earnings of -$0.11 per share, missing the Zacks Consensus Estimate of $0.03 per share. This reflects a negative earnings surprise of 466.67%. Look out for DVAX's next earnings release on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.12 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for DVAX
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
TG Therapeutics (TGTX) Lags Q1 Earnings Estimates
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP
DVAX FAQs
Dynavax Technologies Corporation (DVAX) has announced they will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.12 per share, reflecting a year-over-year increase of 50.00%.
Dynavax Technologies Corporation has announced they will report their previous quarter earnings after the close of the market on August 07, 2025.
The Zacks Consensus Estimate for Dynavax Technologies Corporation (DVAX) for the quarter ending June 2025 is $0.12 a share. We expect Dynavax Technologies Corporation (DVAX) to report earnings in line with the consensus estimate of $0.12 per share
In the earnings report for the quarter ending in June 2024, Dynavax Technologies Corporation (DVAX) announced earnings of $0.08 per share versus the Zacks Consensus Estimate of $0.06 per share, representing a surprise of 33.33%.